Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Veracyte, Inc. (VCYT)  
$20.12 0.91 (4.33%) as of 4:30 Wed 5/8


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 82,823,000
Market Cap: 1.67(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.92 - $29.92
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  484
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Veracyte is a genomic diagnostics company. Co. develops tests that address clinical needs in the diagnosis, prognosis and treatment of cancer and other diseases. Co. provides tests in: thyroid cancer via its Afirma Genomic Sequencing Classifier (GSC) and Xpression Atlas; prostate cancer via its Decipher Biopsy and Radical Prostatectomy Genomic Classifiers; breast cancer via its Prosigna Breast Cancer Assay; lung cancer via its Percepta GSC and Percepta Nasal Swab Test; interstitial lung diseases including idiopathic pulmonary fibrosis via its Envisia Genomic Classifier; bladder cancer via its Decipher Bladder Genomic Classifier; and colon cancer via its Immunoscore Colon Cancer Test.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 60,000
Total Buy Value $0 $0 $0 $980,094
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 20,000 20,000 104,169 535,146
Total Sell Value $460,127 $460,127 $2,968,197 $14,025,264
Total People Sold 2 2 4 8
Total Sell Transactions 2 2 12 30
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 524
  Page 6 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2022-03-02 4 D $27.84 $287,782 D/D (10,337) 37,575     -
   Nova Tina Susan President, CLIA U.S.   •       –      –    2022-03-02 4 D $27.84 $297,749 D/D (10,695) 20,442     -
   Anderson Bonnie H Executive Chairwoman   •       •      –    2022-03-02 4 D $27.84 $125,865 D/D (4,521) 69,021     -
   Wygant Jonathan VP, Chief Accounting OfficerOf   •       –      –    2022-03-01 3 IO $0.00 $0 D/D 0 12,000 -12%     
   Mcguire Annie SVP, General Counsel   •       –      –    2022-02-28 4 A $0.00 $0 D/D 22,855 22,855     -
   Jones Evan/ Fa Director   –       •      –    2022-01-11 4 OE $4.00 $20,000 D/D 5,000 43,720     -
   Nova Tina Susan President, CLIA U.S.Officer   •       –      –    2022-01-06 3 IO $0.00 $0 D/D 0 30,000 -48%     
   Eastham Karin Director   –       •      –    2021-12-17 4 AS $45.00 $225,000 D/D (5,000) 8,720 -55%     
   Eastham Karin Director   –       •      –    2021-12-17 4 OE $12.12 $60,600 D/D 5,000 13,720     -
   Anderson Bonnie H Executive Chairwoman   •       •      –    2021-12-09 4 OE $8.86 $99,994 D/D 11,286 73,542     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-12-07 4 AS $39.69 $246,356 D/D (6,125) 47,912 -42%     
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-12-07 4 OE $24.69 $154,481 D/D 6,125 54,037     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-12-06 4 AS $35.37 $332,784 D/D (9,232) 47,912 -38%     
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-12-06 4 OE $5.98 $102,135 D/D 8,156 57,144     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-12-02 4 D $39.22 $35,769 D/D (912) 48,988     -
   Anderson Bonnie H Executive Chairwoman   •       •      –    2021-12-02 4 D $39.22 $89,735 D/D (2,288) 62,256     -
   Eastham Karin Director   –       •      –    2021-11-01 4 AS $47.73 $145,106,339 I/I (4,400) 0 -55%     
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-11-01 4 D $51.80 $7,718 D/D (149) 49,900     -
   Anderson Bonnie H Executive Chairwoman   •       •      –    2021-09-17 4 AS $50.18 $130,478 I/I (2,600) 217,478 -47%     
   Anderson Bonnie H Executive Chairwoman   •       •      –    2021-09-10 4 AS $50.03 $95,050 I/I (1,900) 220,078 -45%     
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-09-08 4 AS $50.53 $46,791 D/D (926) 50,049 -45%     
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-09-07 4 AS $50.52 $633,408 D/D (12,531) 50,975 -46%     
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-09-07 4 OE $5.98 $210,154 D/D 12,531 63,506     -
   Anderson Bonnie H Executive Chairwoman   •       •      –    2021-09-02 4 D $52.97 $121,195 D/D (2,288) 64,544     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-09-02 4 D $52.97 $48,309 D/D (912) 50,975     -
  524 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us